Cargando…
In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant
INTRODUCTION: Cancer cells induced into immunogenic cell death (ICD) in vitro can be directly used as a whole cell vaccine for tumor immunotherapy with many advantages, especially enacting immediate and intense ‘eat me’ signals to engage immune system. Unfortunately, there have been few successes wi...
Autores principales: | Yang, Rong, Zhou, Shanshan, Zhou, Qibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721236/ https://www.ncbi.nlm.nih.gov/pubmed/35003803 http://dx.doi.org/10.1016/j.jare.2021.03.003 |
Ejemplares similares
-
CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015) -
Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways
por: Wei, Qiong, et al.
Publicado: (2015) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012) -
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
por: Li, Yibo, et al.
Publicado: (2023)